These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 39146274)

  • 1. Trends in diabetes medication prescribing from 2018 to 2021: A cross-sectional analysis.
    Riad J; Abdelmalek F; Ivers N; Tadrous M
    PLoS One; 2024; 19(8):e0307451. PubMed ID: 39146274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sodium-glucose co-transporter-2 inhibitors, the latest residents on the block: Impact on glycaemic control at a general practice level in England.
    Heald AH; Fryer AA; Anderson SG; Livingston M; Lunt M; Davies M; Moreno GYC; Gadsby R; Young RJ; Stedman M
    Diabetes Obes Metab; 2018 Jul; 20(7):1659-1669. PubMed ID: 29516618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changing use of antidiabetic drugs in the UK: trends in prescribing 2000-2017.
    Wilkinson S; Douglas I; Stirnadel-Farrant H; Fogarty D; Pokrajac A; Smeeth L; Tomlinson L
    BMJ Open; 2018 Jul; 8(7):e022768. PubMed ID: 30056393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychotropic Medication Prescribing for Children and Adolescents After the Onset of the COVID-19 Pandemic.
    Valtuille Z; Acquaviva E; Trebossen V; Ouldali N; Bourmaud A; Sclison S; Gomez A; Revet A; Peyre H; Delorme R; Kaguelidou F
    JAMA Netw Open; 2024 Apr; 7(4):e247965. PubMed ID: 38652474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A population-based analysis of antidiabetic medications in four Canadian provinces: Secular trends and prescribing patterns.
    Secrest MH; Azoulay L; Dahl M; Clemens KK; Durand M; Hu N; Targownik L; Turin TC; Dormuth CR; Filion KB
    Pharmacoepidemiol Drug Saf; 2020 Jan; 29 Suppl 1():86-92. PubMed ID: 31464069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pattern of prescribing of glucose modulating agents for type 2 diabetes in general practices in England 2016/17.
    Heald AH; Livingston M; Bien Z; Moreno GYC; Laing I; Stedman M
    Int J Clin Pract; 2018 Apr; 72(4):e13080. PubMed ID: 29537664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Change in glucose-lowering medication regimens in individuals with type 2 diabetes mellitus during the COVID-19 pandemic in Germany.
    Jacob L; Rickwood S; Rathmann W; Kostev K
    Diabetes Obes Metab; 2021 Apr; 23(4):910-915. PubMed ID: 33319440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. National Trends in Use of Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-like Peptide-1 Receptor Agonists by Cardiologists and Other Specialties, 2015 to 2020.
    Adhikari R; Jha K; Dardari Z; Heyward J; Blumenthal RS; Eckel RH; Alexander GC; Blaha MJ
    J Am Heart Assoc; 2022 May; 11(9):e023811. PubMed ID: 35475341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative adherence to diabetes drugs: An analysis of electronic health records and claims data.
    Flory J; Gerhard T; Stempniewicz N; Keating S; Rowan CG
    Diabetes Obes Metab; 2017 Aug; 19(8):1184-1187. PubMed ID: 28266807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. National Trends in Diabetes Medication Use in the United States: 2008 to 2015.
    Raval AD; Vyas A
    J Pharm Pract; 2020 Aug; 33(4):433-442. PubMed ID: 30572757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and Incidence of Medication-Treated Diabetes and Pattern of Glucose-Lowering Treatment During the COVID-19 Pandemic: Real-World Data from the Electronic Greek Prescription Database.
    Siafarikas C; Karamanakos G; Makrilakis K; Tsolakidis A; Mathioudakis K; Liatis S
    Exp Clin Endocrinol Diabetes; 2024 Sep; 132(9):515-521. PubMed ID: 38626912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prescribing of diabetes medications to people with type 2 diabetes and chronic kidney disease: a national cross-sectional study.
    Manski-Nankervis JA; Thuraisingam S; Sluggett JK; Kilov G; Furler J; O'Neal D; Jenkins A
    BMC Fam Pract; 2019 Feb; 20(1):29. PubMed ID: 30777033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prescribing Paradigm Shift? Applying the 2019 European Society of Cardiology-Led Guidelines on Diabetes, Prediabetes, and Cardiovascular Disease to Assess Eligibility for Sodium-Glucose Cotransporter 2 Inhibitors or Glucagon-Like Peptide 1 Receptor Agonists as First-Line Monotherapy (or Add-on to Metformin Monotherapy) in Type 2 Diabetes in Scotland.
    Caparrotta TM; Blackbourn LAK; McGurnaghan SJ; Chalmers J; Lindsay R; McCrimmon R; McKnight J; Wild S; Petrie JR; Philip S; McKeigue PM; Webb DJ; Sattar N; Colhoun HM;
    Diabetes Care; 2020 Sep; 43(9):2034-2041. PubMed ID: 32581068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sulfonylurea Prescribing Patterns After the Introduction of DPP-4 Inhibitors and GLP-1 Receptor Agonists.
    Payk SL; Drew RH; Smith JD; Jiroutek MR; Holland MA
    Clin Ther; 2015 Jul; 37(7):1477-1482.e1. PubMed ID: 26024569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of medication initiation in newly diagnosed diabetes mellitus: quality and cost implications.
    Desai NR; Shrank WH; Fischer MA; Avorn J; Liberman JN; Schneeweiss S; Pakes J; Brennan TA; Choudhry NK
    Am J Med; 2012 Mar; 125(3):302.e1-7. PubMed ID: 22340932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time trends and regional variation in utilization of antidiabetic medicines in China, 2015-2022.
    Zhang J; Xu S; Liu X; Zhang J; Hu S; Liu X; Yang C; Fang Y
    Diabetes Obes Metab; 2024 Jul; 26(7):2752-2760. PubMed ID: 38618979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changing Patterns of Antihyperglycaemic Treatment among Patients with Type 2 Diabetes in Hungary between 2015 and 2020-Nationwide Data from a Register-Based Analysis.
    Jermendy G; Kiss Z; Rokszin G; Abonyi-Tóth Z; Lengyel C; Kempler P; Wittmann I
    Medicina (Kaunas); 2022 Oct; 58(10):. PubMed ID: 36295543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetes medication regimens and patient clinical characteristics in the national patient-centered clinical research network, PCORnet.
    Bachmann KN; Roumie CL; Wiese AD; Grijalva CG; Buse JB; Bradford R; Zalimeni EO; Knoepp P; Dard S; Morris HL; Donahoo WT; Fanous N; Fonseca V; Katalenich B; Choi S; Louzao D; O'Brien E; Cook MM; Rothman RL; Chakkalakal RJ
    Pharmacol Res Perspect; 2020 Oct; 8(5):e00637. PubMed ID: 32881317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Application of new glucose lowering drugs: DPP-4 inhibitors, GLP-1 receptor agonists and SGLT-2 inhibitors].
    Verburg AFE; van den Donk M; Wiersma T
    Ned Tijdschr Geneeskd; 2019 Jan; 163():. PubMed ID: 30676706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secular trends in antihyperglycaemic medication prescriptions in older adults with diabetes and chronic kidney disease: 2004-2013.
    Clemens KK; Liu K; Shariff S; Schernthaner G; Tangri N; Garg AX
    Diabetes Obes Metab; 2016 Jun; 18(6):607-14. PubMed ID: 26939711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.